Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome
Rosita Rigoni(Humanitas University), Barbara Cassani(Humanitas University), Julie Alejo(Center for Cancer Research), Andrew R. Gennery(Newcastle upon Tyne Hospitals NHS Foundation Trust), Waleed Al–Herz(Kuwait University), Silvia Giliani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Muthulekha Swamydas(Cleveland Clinic Lerner College of Medicine), Douglas B. Kuhns(Leidos (United States)), Ansgar Schulz(University Hospital Ulm), Michail S. Lionakis(National Institute of Allergy and Infectious Diseases), Despina Moshous(Hôpital Necker-Enfants Malades), Alain Fischer(Inserm), Luigi D. Notarangelo(Harvard University), Veronica Marrella(Institute of Genetic and Biomedical Research), Andrea Finocchi(Bambino Gesù Children's Hospital), Mario Ernesto Cruz‐Muñoz(Universidad Autónoma del Estado de Morelos), Elena Fontana(Institute of Genetic and Biomedical Research), Kerry Dobbs(National Institute of Allergy and Infectious Diseases), Isabelle Meyts(KU Leuven), Danielle Fink(Leidos (United States)), Raif S. Geha(Boston Children's Hospital), Valentina Taverniti(University of Milan), Virginia Maina(Humanitas University), Simone Guglielmetti, Anna Villa(Institute of Genetic and Biomedical Research), Elizabeth Garabedian(National Human Genome Research Institute), Amanda Facoetti(Humanitas University), Ian A. Myles(National Institutes of Health), Thomas Tousseyn(KU Leuven), Ghassan Dbaibo(American University of Beirut), Giovanna D’Amico(University of Milano-Bicocca), Deborah Draper(National Institutes of Health), Stefania Pittaluga(New York University), Catharina Schuetz(Warrington and Halton Teaching Hospitals NHS Foundation Trust), Bénédicte Neven(Université Paris-Panthéon-Assas)
Cited by 29
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k